Epetōme

Seed
epetome.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Feb 18, 2026
Investors Undisclosed
Decision Makers 2 Verified

About Epetōme

a daily pre + probiotic with 11 clinically trialled bacterial strains alongside FOS fibre, vitamin D, zinc and biotin. Duo cap® technology ensures targeted delivery within the gut. Just once a day, every day.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website epetome.com
Domain Registered Date Oct 17, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    Website domain registered

    epetome.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Epetōme.

Funding History

1 Round
Seed equity · Feb 18, 2026
Undisclosed

Founders & Leadership

1

Emily English

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts